Literature DB >> 18055229

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Elke Pogge von Strandmann1, Venkateswara Rao Simhadri, Bastian von Tresckow, Stephanie Sasse, Katrin S Reiners, Hinrich P Hansen, Achim Rothe, Boris Böll, Vijaya Lakshmi Simhadri, Peter Borchmann, Peter J McKinnon, Michael Hallek, Andreas Engert.   

Abstract

The activity of natural killer (NK) cells is regulated by surface receptors, which direct target cell recognition. NKp30 (Natural Cytotoxicity Receptor 3) induces target cell lysis and is also crucial for the interaction with dendritic cells. So far, the cellular ligands for NKp30 have remained elusive. Here we show that the nuclear factor HLA-B-associated transcript 3 (BAT3) was released from tumor cells, bound directly to NKp30, and engaged NKp30 on NK cells. BAT3 triggered NKp30-mediated cytotoxicity and was necessary for tumor rejection in a multiple myeloma model. These data identify BAT3 as a cellular ligand for NKp30. We propose a concept for target cell recognition by NK cells beyond "missing self" and "induced self," mediated through a tumor cell-derived extracellular factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055229     DOI: 10.1016/j.immuni.2007.10.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  157 in total

1.  Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.

Authors:  Caroline Veuillen; Thérèse Aurran-Schleinitz; Rémy Castellano; Jérôme Rey; Françoise Mallet; Florence Orlanducci; Laurent Pouyet; Sylvaine Just-Landi; Diane Coso; Vadim Ivanov; Xavier Carcopino; Réda Bouabdallah; Yves Collette; Cyril Fauriat; Daniel Olive
Journal:  J Clin Immunol       Date:  2012-02-09       Impact factor: 8.317

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 3.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

4.  Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6.

Authors:  Guoshuai Cao; Jian Wang; Xiaodong Zheng; Haiming Wei; Zhigang Tian; Rui Sun
Journal:  J Biol Chem       Date:  2015-10-15       Impact factor: 5.157

5.  NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cells.

Authors:  Elke Pogge von Strandmann; Olga Shatnyeva; Hinrich P Hansen
Journal:  Ann Transl Med       Date:  2015-11

6.  Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.

Authors:  Brenna E Swift; Brent A Williams; Yoko Kosaka; Xing-Hua Wang; Jeffrey A Medin; Sowmya Viswanathan; Joaquin Martinez-Lopez; Armand Keating
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

7.  The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.

Authors:  Stefanie Memmer; Sandra Weil; Steffen Beyer; Tobias Zöller; Eike Peters; Jessica Hartmann; Alexander Steinle; Joachim Koch
Journal:  J Biol Chem       Date:  2016-10-17       Impact factor: 5.157

8.  Enhanced activation of human NK cells by drug-exposed hepatocytes.

Authors:  Frank Fasbender; Martin Obholzer; Sarah Metzler; Regina Stöber; Jan G Hengstler; Carsten Watzl
Journal:  Arch Toxicol       Date:  2020-02-14       Impact factor: 5.153

9.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

10.  The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.

Authors:  Sonja Textor; Felicitas Bossler; Kai-Oliver Henrich; Moritz Gartlgruber; Julia Pollmann; Nathalie Fiegler; Annette Arnold; Frank Westermann; Nina Waldburger; Kai Breuhahn; Sven Golfier; Mathias Witzens-Harig; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.